House of Commons photo

Crucial Fact

  • Her favourite word was quebec.

Last in Parliament March 2011, as Bloc MP for Laval (Québec)

Lost her last election, in 2011, with 23% of the vote.

Statements in the House

Supporting Communities Partnership Initiative October 27th, 2006

Mr. Speaker, organizations have come to shout about it on the Hill. People in the streets are suffering from it. Homelessness is a problem. Why not renew the SCPI? What do people have to do to be heard?

We, the elected members of this House, speak for the voiceless, who will suffer from your uncomprehending refusal to renew the SCPI.

The groups that help these people have come to talk with us and share their concerns, yet this government has turned a deaf ear to them.

No one is immune to mental illness, no one can swear that they will not sink into alcoholism, no one can promise that they will never suffer from depression. No one wants to wind up on the street, yet this government is refusing to tell the homeless whether it will provide the necessary funding for the organizations that help them and that are often their only hope.

The Bloc Québécois is calling on the government to enhance the SCPI, make it permanent and transfer it to Quebec.

Health October 26th, 2006

Mr. Speaker, will the minister admit that the study on which he based his decision to allow breast implants does not deal with ruptured devices or the diseases caused by ruptured devices, which means that it is incomplete and does not provide the minister with the essential data on which to base a decision?

Health October 26th, 2006

Mr. Speaker, he cannot name even one expert.

This minister, who has let himself be fooled by the breast implant lobby, is endangering women's health.

Does the minister realize that he is taking responsibility for what will happen to women in 10 or 15 years, on the basis of opinions from experts who are connected to the companies that sell implants?

Health October 26th, 2006

Mr. Speaker, I accuse the Minister of Health of acting irresponsibly toward women. He recently authorized silicone breast implants again, basing his decision on evaluations carried out by experts connected with the companies that want to capture the market, no less.

Can he name me a single expert who is not connected somehow to the companies that sell implants? I would like him to name me just one expert. His department was unable to do so.

Health October 25th, 2006

Mr. Speaker, the minister even added that all the researchers trust the newly approved breast implants.

How can he be satisfied with so little, when the Health Canada officials who met with me were not even able to name me single independent researcher? All the researchers they named were associated with the two companies that produce the breast implants.

Health October 25th, 2006

Mr. Speaker, yesterday, the Minister of Health justified his decision to authorize the use of breast implants by stating that more than 65,000 pages of documents had been studied before licences had been issued.

How can he be so naive when we know that nearly all these documents were provided by Mentor and Inamed, the two companies that sell implants?

Health October 24th, 2006

Mr. Speaker, last Friday, Health Canada allowed the reintroduction of silicone breast implants by granting licences to the Mentor and Inamed corporations.

Could the Minister of Health and Minister for the Federal Economic Development Initiative for Northern Ontario tell us why Health Canada took such a decision when new allegations made on October 12 by a former Mentor scientist, according to whom the company provided the U.S. Food and Drug Administration with inaccurate safety data, cast legitimate doubt on the safety of silicone breast implants?

Breast Cancer Awareness Month October 18th, 2006

Mr. Speaker, October is Breast Cancer Awareness Month. Breast cancer is the most common cancer among women. In 2006, 22,000 women will be diagnosed with breast cancer. That is an increase of nearly 400 cases compared to 2005. Of those 22,000 women, 5,300 will die of the disease.

As a former victim of breast cancer, I know how devastating it can be, how it makes its victims feel powerless and discouraged, and how painful it is for the victims, their families and their friends.

Correcting the fiscal imbalance is critical to ensuring the provinces have more money to prevent, diagnose and treat breast cancer.

The federal government must also invest more money in research and refuse to issue licences for silicone gel breast implants, which can contribute to causing cancer.

I invite my colleagues to support this cause and the thousands of women who have breast cancer.

Hazardous Materials Information Review Act October 16th, 2006

Mr. Speaker, I thank my colleague for her speech. She was very well prepared, and it showed. But I would like to ask her a question about the responsibility of companies that make hazardous products. We know that the Hazardous Materials Information Review Commission conducts ongoing evaluations to determine whether these products are always properly used, properly packaged and properly transported.

In the past four years—2003, 2004, 2005 and 2006—there were fairly serious problems that, I think, deserve our attention. For example, there were 92 very serious violations where the concentration ratio of hazardous ingredients was missing or incorrect; 147 violations in 2004-05 involving preparation information, where the preparer's name or telephone number was missing; 101 violations concerning reactivity or incompatibility with other products; 119 violations regarding the effects of acute exposure, that is, toxicological properties; 127 violations pertaining to the effects of chronic exposure; and 85 violations regarding exposure limits. Products therefore had no documentation on the effects they could have on the people who use them. With respect to first aid, there were 80 instances where manufacturers of first aid products even removed the advice to administer water in cases of ingestion and 84 instances where there was no description of how to treat people in the event of skin contact with a product.

In my opinion, this is very important. In the years covered by the commission's report, roughly 45% of all violations regarding “effects of acute exposure” for all routes of entry involved failure to disclose that the product has harmful effects on the central nervous system.

I would like my dear colleague, who works with me on the health committee, to give me her opinion of these data and statistics. In my opinion, even though we are giving companies permission to be more efficient, we must also ensure that products that are sold are safe.

Hazardous Materials Information Review Act October 16th, 2006

Mr. Speaker, I am very pleased to rise in this House today to speak to Bill S-2.

Of course, as always, the Bloc Québécois agrees with what tends to be reasonable. We are very responsible. This is why we thoroughly examined the changes proposed by Bill S-2. If this can help businesses to improve their performance and their effectiveness, we agree. However, we must also be careful, because, even through we agree with what makes sense, we know that errors can sometimes happen. Because we agree with Bill S-2, we would not want Health Canada to think that we agree with everything that is related to the hazardous product problem.

Hazardous products have caused, many times in the past, incidents and major accidents that have left some people handicapped for life and that have even killed others. We only have to think about the case of Produits chimiques Expro inc. in Quebec. We are being very careful and very vigilant in the implementation of this bill.

I had the opportunity to speak with my colleague from Beauharnois—Salaberry about this bill and hazardous materials. She used to work in a hospital setting. She had the responsibility of explaining to people under her direction how hazardous products had to be used. Of course, when we talk about hazardous products, we are talking about products that may be very toxic. She thinks that this approach is working very well; it is very easy to explain to people. However, she was also telling me that there was not enough time. There was not enough time and, very often, unfortunately, the French versions of WHMIS data sheets were very slow in coming. Businesses should solve this problem, because, when one works in a hospital setting, one is in contact with people who are often very vulnerable and cannot always defend themselves against invasions of bacteria that might come from certain products.

One of her tasks was to explain how to use those products. She was responsible for health and safety but found that employees did not have time to inform themselves. She had to give them the information in the corridors, between two rooms. She regretted that because those dangerous products caused considerable damage. However, I find the amendments to the original act very valuable and legitimate. We can understand the desire to help companies; it was not really necessary to provide the government with the information requested by companies, as long as the companies respected appropriate confidentiality. That way, we know that they will act with full knowledge of the facts and very responsibly.

In comparison, the present legislation forces the HMIRC to give an official compliance order, even if the company which requests an exemption is ready to respect its obligations and to make the necessary changes after being served notice. The process in the present legislation is time consuming and strict. The order sent to companies must be published in the Canada Gazette and is enforceable 75 days later. There are further delays to allow the company to appeal the order and to produce a new data sheet. Once again, in many companies in Quebec and Canada the most obvious language is English. As the sheets must be translated, that unfortunately adds a little too much time. That is regrettable because if the people who have to work with the products cannot read the sheets and understand them correctly they will be at risk.

The HMIRC will also be in a position to give information and to clarify the cases under appeal. Right now, the independent appeal boards cannot consult the commission.

Nonetheless, some aspects worry me, as far as hazardous materials are concerned, and I am not just talking about their composition. We know that often accidents occur in the transportation of these materials. I think we must ensure, for the transportation of hazardous products, that every appropriate safety measure is taken to avoid accidents from happening to people who earn their living under difficult circumstances and who work very hard; people like truck drivers and their helpers, who unfortunately do not always have the luxury of defending themselves because they are not part of a union.

We also know that many questions remain on the choices made by firefighters. There are also many questions about the choices made by transport companies. They have to keep increasing their productivity and efficiency. The cost of gas is so high they have to keep their trucks on the road day and night to earn a decent income, which—even at that—is not guaranteed. Anything that allows companies to put their products on the market in a more diligent manner is fine by us. However, it is important to ensure that these trucking companies and other transport companies are just as diligent in the application of safety measures for their products when it comes to dangers and difficulties.

I also want to note that a number of times now, institutions, even schools, have had to be evacuated because of problems with toxic and hazardous materials.

Take for example an incident that occurred in May 2005 when the handling of nitric acid forced the evacuation of a thousand or so people from the chemistry and biochemistry department at the Université du Québec à Montréal. The incident occurred in a lab when a researcher was busy pouring nitric acid in a recycled container and a chemical reaction ensued. It is very dangerous. A lot of students and other people on site could have suffered extremely unfortunate consequences. Fortunately, this was not the case. The incident was classed as a true accident because the product was not defective. The problem was in the way the product was handled by the professor. The company was not at fault.

There was also the release of a toxic cloud in Valleyfield. Environment Canada monitors 585 facilities in Quebec that may pose a risk, because they store substances deemed hazardous, such as the sulphuric anhydride that was released at Noranda's CEZinc plant, in Valleyfield. That plant is not governed by Health Canada and Environment Canada's regulations. In fact, it does not store that product. The sulphuric anhydride is merely transiting through the plant in its pools. That plant is not deemed to be a facility that stores toxic and hazardous products, and it is not subject to the same regulations. This is why accidents such as the one that occurred in Valleyfield, on the evening of August 12, 2004, can happen. People living close to the plant had to be evacuated, because an extremely toxic product had been released, thus creating a very dangerous situation.

A chemical product also caused a number of people to faint at a flea market. Flea markets are very popular in Quebec and families enjoy going there on Saturdays and Sundays. So, when incidents like that occur in such locations, we are concerned about people's health and safety. When people faint because of a chemical product, it means that the substance is really very potent. We do not always know the origin of that chemical product, and we may also not know what it is exactly.

People try to find out where the product came from, but to no avail. This raises some important questions.

I know the companies that make these products are very competent and do as much as they can to ensure that such incidents do not occur. However, humans being what they are, unfortunate things sometimes happen.

I completely agree that we should give companies the opportunity to get their products to market faster and more efficiently. I am pleased with this move to amend the act because it is a little restrictive.

We have strong environmental convictions. Even though some members and government ministers claim that the environment is responsible for a number of plant and business closures, we know that is not true. We know that this is not the principal cause of plant and business closures.

We do not put much stock in such simplistic explanations. We try to do our homework and study the issue in its entirety before making a decision about whether to support this or that bill.

This bill is not a problem for us because its implementation does not directly put anybody’s life in danger. The change that is requested is minimal and only speeds up a process that we know is very long. In all departments, the approval processes are very long.

For example, just in the area of natural health products, some companies have to wait as many as two, three or even four years to get a product evaluated and recognized by Health Canada. These waiting periods are senseless because, after all, some of these products are used by a lot of people all over the world and have very conclusive effects on their health. I myself have been taking some for a number of years, and as you can see, I am in excellent health.

All of this to say that there is not much in the bill that would cause us to oppose it. We cannot be against virtue itself. Unlike the governing party, which seems to be against all environmental virtue, we do not think that a bill like this has any environmental effect at all.

We will therefore be very much in favour of the bill in principle. We hope that hon. members of all parties will also support it because we think that the passage of this bill will make all our companies in Quebec and Canada more efficient. We also believe that the committees charged previously with assessing hazardous products have done a good job of evaluating the implications of this amendment.

This is an amendment, therefore, that will in no way compromise the safety or all the precautions that should be taken to ensure that hazardous products are properly stored, used and provided to customers, as well as properly transported. We also believe that the owners of the companies that produce these hazardous products are competent people who ensure that their products are used properly and who will do even more in the future to ensure that their products include data sheets translated into French as well as English ones so that people who use the products have the information they need more quickly.